Adial Pharmaceuticals Statistics

Total Valuation

ADIL has a market cap or net worth of $2.24 million. The enterprise value is -$3.65 million.

Market Cap	2.24M
Enterprise Value	-3.65M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

ADIL has 1.43 million shares outstanding. The number of shares has increased by 244.55% in one year.

Current Share Class	1.43M
Shares Outstanding	1.43M
Shares Change (YoY)	+244.55%
Shares Change (QoQ)	+23.36%
Owned by Insiders (%)	2.21%
Owned by Institutions (%)	2.75%
Float	1.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.33
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.42

Current Ratio	4.42
Quick Ratio	4.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -170.73% and return on invested capital (ROIC) is -104.33%.

Return on Equity (ROE)	-170.73%
Return on Assets (ROA)	-83.20%
Return on Invested Capital (ROIC)	-104.33%
Return on Capital Employed (ROCE)	-147.82%
Weighted Average Cost of Capital (WACC)	11.94%
Revenue Per Employee	n/a
Profits Per Employee	-$1.60M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.01% in the last 52 weeks. The beta is 1.40, so ADIL's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	-91.01%
50-Day Moving Average	1.89
200-Day Moving Average	6.59
Relative Strength Index (RSI)	33.27
Average Volume (20 Days)	96,480

Short Selling Information

The latest short interest is 49,013, so 3.43% of the outstanding shares have been sold short.

Short Interest	49,013
Short Previous Month	96,887
Short % of Shares Out	3.43%
Short % of Float	3.82%
Short Ratio (days to cover)	0.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.80M
Pretax Income	-7.98M
Net Income	-7.98M
EBITDA	-7.80M
EBIT	-7.80M
Earnings Per Share (EPS)	-$11.93

Full Income Statement

Balance Sheet

The company has $5.88 million in cash and n/a in debt, giving a net cash position of $5.88 million or $4.12 per share.

Cash & Cash Equivalents	5.88M
Total Debt	n/a
Net Cash	5.88M
Net Cash Per Share	$4.12
Equity (Book Value)	5.28M
Book Value Per Share	4.75
Working Capital	4.78M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.49M
Capital Expenditures	n/a
Depreciation & Amortization	565
Net Borrowing	n/a
Free Cash Flow	-6.49M
FCF Per Share	-$4.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ADIL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-244.55%
Shareholder Yield	-244.55%
Earnings Yield	-358.10%
FCF Yield	-291.46%

Analyst Forecast

The average price target for ADIL is $37.50, which is 2,288.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.50
Price Target Difference	2,288.54%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 6, 2026. It was a reverse split with a ratio of 1:25.

Last Split Date	Feb 6, 2026
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	2